Consumer Confidential: Less choice, higher prices feared in CVS's takeover of health insurer Aetna
CVS Health says that its planned $69 billion takeover of insurance giant Aetna would be good for consumers. That, of course, is unlikely.
For the deal to benefit consumers, it would have to result in lower drug prices or lower insurance costs. If past experience is anything to go by, this won't happen.
"You don't need a crystal ball to predict the future here," said David Balto, a health care advocate and former policy director for the Federal Trade Commission.
Such deals "have a dismal history," he told
